Cultural Warning: Aboriginal and Torres Strait Islander viewers are advised that our films may contain images of people who have since passed away.
Hepatitis Victoria is the peak not-for-profit community organisation working across the state for people affected by or at risk of viral hepatitis. We work to prevent the transmission of viral hepatitis, increase access and referral to quality viral hepatitis information, care, treatment and support, and provide leadership and coordination for the community response to viral hepatitis. We also work with government, media and other agencies to promote a stronger response to the challenges of viral hepatitis in our community.
Hepatitis Victoria is a statewide, not for profit, community based, public health organisation committed to reducing the impact of viral hepatitis. Hepatitis Victoria provides information, support, referral, education and advocacy for people living with viral hepatitis and training for those who work with them.
An early clinical trial of a hepatitis C vaccine has shown ‘promising’ results, according to British researchers at Oxford University.
Designing a vaccine for hepatitis C has been difficult as the virus changes its appearance, making it hard to find something to target. Writing in Science Translational Medicine, researchers say their trial on 41 patients shows it is possible to target.
China has approved a hepatitis E vaccine, claimed to be the world's first. In China the incidence of hepatitis E has increased notably and become the most common among all types of hepatitis infecting adults in that country. The vaccine received a certificate for medicine production in December 2011.
Hep C: Take Control is Hepatitis Victoria’s six week program for people with hepatitis C who want to better manage their health and would like support to make healthy choices. In 2012 Hep C: Take Control is being conducted in partnership with Integrated Hepatitis C Service Nurses around the state.
This workshop is designed for drug and alcohol workers, nurses, NSP workers, community health staff, students of health professions, prison staff and welfare workers. No prior knowledge is assumed.
The CHI (Charting Health Impacts) Study is about the impact of hepatitis C on peoples’ lives. The study follows a group of people over time – looking at all the health and social aspects of life – so they can tell community organisations, doctors and governments what it is really like to live with hepatitis C.
